Chemistry professor at Columbia University with research background in synthetic and medicinal chemistry, molecular imaging, and neuropharmacology. His work has included research on C-H bond functionalization methods, fluorescent probes for synaptic imaging, and the pharmacology of various natural alkaloids.
Intro paths
YC
Dalibor went through Y Combinator (Summer 2020) — any YC alum in your network can reach them through the YC community.
GP
Their group partner at YC was Jared Friedman, General Partner at Y Combinator — the partner who ran Gilgamesh Pharmaceuticals's batch and knows the company first-hand. YC profile ↗
→
In turn, Dalibor can intro founders to Gilgamesh Pharmaceuticals's investors below.
Gilgamesh Pharmaceuticals's investors · 10
Co-founders
JS
Jonathan SpornFounder
AK
Andrew KruegelFounder
JS
JONATHAN SPORNFounder
TK
Thomas Kevin Murphy, Ph.D.Executive Officer
AK
Andrew Kruegel, Ph.D.Executive Officer
JS
Jonathan Sporn, M.D.President and Chief Executive Officer